Eli Lilly Targets Telehealth Firms Over Unauthorized Weight-Loss Drug Variants
Pharma giant intensifies legal action against Mochi Health, Fella Health, Willow Health, and Henry Meds for distributing unapproved tirzepatide formulations
Contributor:
Rachel Steinberg